Cargando…
OnabotulinumtoxinA in Migraine: A Review of the Literature and Factors Associated with Efficacy
The efficacy of onabotulinumtoxinA (OnaB-A) as a preventative treatment for chronic migraine, emerging fortuitously from clinical observation is now supported by class one evidence and over two decades of real-world clinical data. There is still limited ability to predict a clinically meaningful res...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269087/ https://www.ncbi.nlm.nih.gov/pubmed/34209849 http://dx.doi.org/10.3390/jcm10132898 |